HEALTHY NEWBORN JAUNDICES: CAUSES, COURSE, PROGNOSIS
https://doi.org/10.21518/2079-701X-2017-19-120-125
Abstract
Jaundice in newborns is the most common symptom and in the vast majority of cases reflects the characteristics of bilirubin metabolism in the neonatal period. In healthy newborns there are two kinds of jaundice that do not require treatment and are caused by hyperbilirubinemia: physiologic and breastfeeding ones. Transient disturbance of the bilirubin clearance (indirect bilirubin conjugation) not affecting the child development lies at the core of a healthy newborn jaundice. Jaundice of breastfeeding differs by prolonged course (up to 2-3 months) while physical and psychomotor development of the child is not affected. However prolonged course (over 14 days of life) of jaundice requires determination of bilirubin and its fractions in dynamics to rule out more serious causes of hyperbilirubinemia.
About the Authors
A. N. Goryanova
Russian Medical Academy of Continuous Postgraduate Education of the Ministry of Health of Russia
Russian Federation
PhD in medicine
Russian Federation
PhD in medicine
M. A. Antsupova
Bashlyaeva Children Municipal Clinical Hospital
Russian Federation
Moscow
Russian Federation
Moscow
I. N. Zakharova
Russian Medical Academy of Continuous Postgraduate Education of the Ministry of Health of Russia
Russian Federation
Russian Federation
References
1. Nelson Textbook of Pediatrics, 20th Edition. Edited by Kliegman RM, Stanton BF, St Geme JW, Schor NF. 2016. 3474 p.
2. Memon N, Weinberger BI, Hegyi T and Aleksunes LM. Inherited Disorders of Bilirubin Clearance. Pediatr Res, 2016 March, 79(3): 378–386. doi:10.1038/pr.2015.247.
3. Onishi S, Kawade N, Itoh S et al. Postnatal development of uridine diphosphate glucuronyltransferase activity towards bilirubin and 2-aminophenol in human liver. Biochem J, 1979, 184: 705–7.
4. Maisels MJ. Chapter in effective care of the newborn infant. In: Sinclair JC, Bracken MA, editors. Oxford, UK: Oxford Medical Publications, 1992: 507–61.
5. Maisels MJ, Gifford K, Antle CE, Leib GR. Jaundice in the Healthy Newborn Infant: A New Approach to an Old Problem. Pediatrics, 1988 Apr, 81(4): 505-11.
6. Fujiwara R, Maruo Y, Chen S, Tukey RH. Role of extrahepatic UDP-glucuronosyltransferase 1A1: Advances in understanding breast milk-induced neonatal hyperbilirubinemia. Toxicol Appl Pharmacol, 2015 Nov 15, 289(1): 124-132.
7. Шерлок Ш., Дули Дж. Заболевания печени и желчных путей. Пер с англ. М.: ГЭОТАР, 1999. 860 с.
8. Newman AJ and Gross S. Hyperbilirubinemia in breast-fed infants. Pediatrics, 1963, 32: 995.
9. Arias IM, Gartner LM, Seifter S and Furman M. Prolonged Neonatal Unconjugated Hyperbilirubinemia Associated with Breast Feeding and a Steroid, Pregnane-3 (Alpha), 20 (Beta) -Diol, in Maternal Milk That Inhibits Glucuronide Formation In Vitro. Journal of Clinical Investigation, 1964, 43(11): 2037-2047.
10. Gartner LM. Breastfeeding and Jaundice. J Perinatol, 2001 Dec, 21(Suppl 1): S25-29, discussion S35-39.
11. Maruo Y, Morioka Y, Fujito H et al. Bilirubin Uridine Diphosphate-Glucuronosyltransferase Variation Is a Genetic Basis of Breast Milk Jaundice. J Pediatr, 2014 July, 165(1): 36–41.e1. doi:10.1016/j.jpeds.2014.01.060.
12. Lucey J, Ferreiro M, Hewitt J. Prevention of hyperbilirubinemia of prematurity by phototherapy. Pediatrics, 1968, 41: 1047.
Review
For citations:
Goryanova AN, Antsupova MA, Zakharova IN. HEALTHY NEWBORN JAUNDICES: CAUSES, COURSE, PROGNOSIS. Meditsinskiy sovet = Medical Council. 2017;(19):120-125. (In Russ.) https://doi.org/10.21518/2079-701X-2017-19-120-125
Views:
990
Email this article 